Erwin R. Boghaert - Concepedia

Author

Erwin R. Boghaert

Also Known As

A. Phillips, Boghaert, Erwin, E Boghaert, E R Boghaert, E. Boghaert, E. R. Boghaert, E.R. Boghaert, Erwin Boghaert, Erwin R Boghaert, Erwin R. Boghaert

185

Publications

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)Pearl River Community College University of Kentucky Instituto de Biologia Experimental e Tecnológica Universidade Nova de Lisboa

About

Erwin R. Boghaert is an author at AbbVie (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	5.1K
2	Health Sciences	2	2	3K
3	Engineering	1	1	115
4	Allergy	1	1	70
5	Biomedical Engineering	1	1	115

Erwin R. Boghaert

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets Andrew J. Souers, Erwin R. Boghaert, Scott Ackler, Nature Medicine ThrombopoiesisThrombosisHematological MalignancyOncologyAntitumor Activity	2013	2.9K
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy Darren C. Phillips, Michael J. Mitten, Erwin R. Boghaert, Science Translational Medicine Cancer TherapyChemoprevention StrategyBcl-2/bcl-xl/bcl-w Inhibitor Abt-263ImmunologyPharmacotherapy	2015	530
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert, Blood	2003	354
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity Zhi‐Fu Tao, Lisa Hasvold, Le Wang, ACS Medicinal Chemistry Letters	2014	328
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models Elizabeth A. Punnoose, Franklin Peale, Erwin R. Boghaert, Molecular Cancer Therapeutics Hematological MalignancyTumor BiologyMedicineImmunologyPharmacology	2016	307
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery Kristin Stock, Marta F Estrada, Suzana Vidic, Scientific Reports	2016	239
Expression and Function of the Leucine Zipper Protein Par-4 in Apoptosis Stephen F. Sells, Seong‐Su Han, Sumathi Muthukkumar, Molecular and Cellular Biology	1997	204
5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis Sha Jin, Dan Cojocari, Julie J. Purkal, Clinical Cancer Research	2020	187
Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208 Andrew J. Souers, Erwin R. Boghaert, Scott Ackler, ThrombosisMolecular PharmacologyBlood PlateletNat MedMedicine	2013	182
ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya, Molecular Cancer Therapeutics Tumor BiologyDrug TargetingTumor-selective Egfr EpitopeMedicineImmunology	2016	175

Page 1